Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

Wei JT, Feng Z, Partin AW, Brown E, Thompson I, Sokoll L, Chan DW, Lotan Y, Kibel AS, Busby JE, Bidair M, Lin DW, Taneja SS, Viterbo R, Joon AY, Dahlgren J, Kagan J, Srivastava S, Sanda MG.

J Clin Oncol. 2014 Dec 20;32(36):4066-72. doi: 10.1200/JCO.2013.52.8505. Epub 2014 Nov 10.

2.

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS, Horwitz EM, Kantoff PW, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Rosenfeld S, Srinivas S, Strope SA, Tward J, Twardowski P, Walsh PC, Ho M, Shead DA.

J Natl Compr Canc Netw. 2012 Sep;10(9):1081-7.

PMID:
22956807
3.

Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach.

Knox ML, El-Galley R, Busby JE.

J Endourol. 2013 Jan;27(1):40-4. doi: 10.1089/end.2012.0168. Epub 2012 Oct 11.

PMID:
22788707
4.

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Messing E, Gee JR, Saltzstein DR, Kim K, diSant'Agnese A, Kolesar J, Harris L, Faerber A, Havighurst T, Young JM, Efros M, Getzenberg RH, Wheeler MA, Tangrea J, Parnes H, House M, Busby JE, Hohl R, Bailey H.

Cancer Prev Res (Phila). 2012 Apr;5(4):621-30. doi: 10.1158/1940-6207.CAPR-11-0455. Epub 2012 Jan 31.

5.

Health policy: lost in transition, losing money, but caution precludes a "quick fix".

Demark-Wahnefried W, Busby JE.

Nat Rev Urol. 2011 Dec 13;9(1):14-6. doi: 10.1038/nrurol.2011.205. No abstract available.

6.

Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients.

Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R, Wallen EM, Woods M, Pruthi RS.

J Laparoendosc Adv Surg Tech A. 2012 Jan-Feb;22(1):17-21. doi: 10.1089/lap.2011.0326. Epub 2011 Dec 5.

PMID:
22142028
7.

Outcome of hand assisted laparoscopic bilateral native nephrectomy in transplant recipients.

El-Galley R, Safavy S, Busby JE, Colli J.

J Urol. 2011 Mar;185(3):1021-5. doi: 10.1016/j.juro.2010.10.084. Epub 2011 Jan 19.

PMID:
21251679
8.

NCCN clinical practice guidelines in oncology: prostate cancer early detection.

Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT.

J Natl Compr Canc Netw. 2010 Feb;8(2):240-62. No abstract available.

PMID:
20141680
9.

NCCN clinical practice guidelines in oncology: prostate cancer.

Mohler J, Bahnson RR, Boston B, Busby JE, D'Amico A, Eastham JA, Enke CA, George D, Horwitz EM, Huben RP, Kantoff P, Kawachi M, Kuettel M, Lange PH, Macvicar G, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Roth BJ, Shrieve DC, Smith MR, Srinivas S, Twardowski P, Walsh PC.

J Natl Compr Canc Netw. 2010 Feb;8(2):162-200. No abstract available.

PMID:
20141676
10.

Editorial comment.

Busby JE.

J Urol. 2010 Jan;183(1):93. doi: 10.1016/j.juro.2009.08.205. No abstract available.

PMID:
19942230
11.

Association between lymph node density and disease specific survival in patients with penile cancer.

Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA.

J Urol. 2009 Dec;182(6):2721-7. doi: 10.1016/j.juro.2009.08.029. Epub 2009 Oct 17.

PMID:
19837433
12.

Salvage therapy for prostate cancer recurrence after radiation therapy.

Cox JM, Busby JE.

Curr Urol Rep. 2009 May;10(3):199-205. Review.

PMID:
19371477
13.

Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.

Yang JC, Ok JH, Busby JE, Borowsky AD, Kung HJ, Evans CP.

Cancer Res. 2009 Jan 1;69(1):151-60. doi: 10.1158/0008-5472.CAN-08-0442.

14.

Renal cell carcinoma rates compared with health status and behavior in the United States.

Colli JL, Busby JE, Amling CL.

Urology. 2009 Feb;73(2):431-6. doi: 10.1016/j.urology.2008.06.044. Epub 2008 Aug 13.

PMID:
18701146
15.

Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic.

Busby JE, Brown GA, Matin SF.

Urology. 2008 Mar;71(3):413-6. doi: 10.1016/j.urology.2007.10.028.

PMID:
18342175
16.

Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?

Spiess PE, Busby JE, Jordan JJ, Steinberg JR, Bassett RL, Davuluri R, Burt K, Troncoso P, Lee AK, Taylor SH, Pisters LL.

Urol Oncol. 2008 Jan-Feb;26(1):25-30. doi: 10.1016/j.urolonc.2006.12.019. Epub 2007 Oct 18.

PMID:
18190826
17.

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy.

Brown GA, Matin SF, Busby JE, Dinney CP, Grossman HB, Pettaway CA, Munsell MF, Kamat AM.

Urology. 2007 Aug;70(2):252-6.

18.

Treatment outcomes of small cell carcinoma of the prostate: a single-center study.

Spiess PE, Pettaway CA, Vakar-Lopez F, Kassouf W, Wang X, Busby JE, Do KA, Davuluri R, Tannir NM.

Cancer. 2007 Oct 15;110(8):1729-37.

19.

Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation.

Spiess PE, Izawa JI, Bassett R, Kedar D, Busby JE, Wong F, Eddings T, Tamboli P, Pettaway CA.

J Urol. 2007 Jun;177(6):2157-61.

PMID:
17509308
20.

Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma.

Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA.

J Urol. 2007 Apr;177(4):1335-8.

PMID:
17382727
21.

Laparoscopic radical nephroureterectomy for transitional cell carcinoma: where are we in 2007?

Busby JE, Matin SF.

Curr Opin Urol. 2007 Mar;17(2):83-7. Review.

PMID:
17285015
22.

Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?

Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL.

BJU Int. 2007 Feb;99(2):321-5. Epub 2006 Nov 28.

23.

Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?

Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF.

BJU Int. 2006 Dec;98(6):1176-80.

24.

Chemoprevention for bladder cancer.

Busby JE, Kamat AM.

J Urol. 2006 Nov;176(5):1914-20. Review.

PMID:
17070211
25.
26.

Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy.

Izawa JI, Busby JE, Morganstern N, Vakar-Lopez F, Scott SM, Pisters LL.

BJU Int. 2006 Sep;98(3):554-8.

27.

Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.

Kim SJ, Uehara H, Yazici S, Busby JE, Nakamura T, He J, Maya M, Logothetis C, Mathew P, Wang X, Do KA, Fan D, Fidler IJ.

J Natl Cancer Inst. 2006 Jun 7;98(11):783-93.

PMID:
16757703
28.

Upper urinary tract tumors with nontransitional histology: a single-center experience.

Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF.

Urology. 2006 Mar;67(3):518-23.

PMID:
16527570
29.

What's new in the management of penile cancer?

Busby JE, Pettaway CA.

Curr Opin Urol. 2005 Sep;15(5):350-7. Review.

PMID:
16093861
30.
31.
32.

Angiogenesis is not mediated by prostate cancer neuropeptides.

Busby JE, Shih SJ, Yang JC, Kung HJ, Evans CP.

Angiogenesis. 2003;6(4):289-93.

PMID:
15166497
33.

Ureteroscopic treatment of renal calculi.

Busby JE, Low RK.

Urol Clin North Am. 2004 Feb;31(1):89-98. Review.

PMID:
15040405
34.

Determining variables for repeat prostate biopsy.

Busby JE, Evans CP.

Prostate Cancer Prostatic Dis. 2004;7(2):93-8. Review.

PMID:
14993898
35.

Paratesticular rhabdomyoma.

Kurzrock EA, Busby JE, Gandour-Edwards R.

J Pediatr Surg. 2003 Oct;38(10):1546-7.

PMID:
14577086
36.

The management of stage T1 grade 3 transitional cell carcinoma of the bladder.

Evans CP, Busby JE.

BJU Int. 2003 Sep;92(4):345-8. Review. No abstract available.

37.

Klinefelter's syndrome and precocious puberty: a harbinger for tumor.

Kurzrock EA, Tunuguntla HS, Busby JE, Gandour-Edwards R, Goldman LA.

Urology. 2002 Sep;60(3):514.

PMID:
12350505
38.

The effect of nicotine on in vitro sperm motion characteristics.

Reddy A, Sood A, Rust PF, Busby JE, Varn E, Mathur RS, Mathur S.

J Assist Reprod Genet. 1995 Mar;12(3):217-23.

PMID:
8520189

Supplemental Content

Loading ...
Support Center